Back to search
FDAFDA · Food and drugs·Recall number D-1258-2019

Test D (TESTOSTERONE CYPIONATE 200MG/ML VITAMIN D3 5,000IU/ML), 5 ML MULTIDOSE VIAL COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

Published May 8, 2019 · Recall initiated: April 8, 2019

Summary

FDA records drug Class II recall D-1258-2019, published May 8, 2019 and initiated April 8, 2019. Recalling firm: Customceutical Compounding; Status: Terminated; Reported quantity: 8 vials; Lot: Lot #: 01232019@25, Exp 4/23/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility for injectables and solutions intended to be sterile.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Customceutical Compounding
Distributor
U.S.A. Nationwide
Lot
Lot #: 01232019@25, Exp 4/23/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Test D (TESTOSTERONE CYPIONATE 200MG/ML VITAMIN D3 5,000IU/ML), 5 ML MULTIDOSE VIAL COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272 recalled?

Yes. FDA published recall D-1258-2019 on May 8, 2019. Reported hazard: Lack of assurance of sterility for injectables and solutions intended to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit